Presentation
14 August 2019 Photodynamic therapy of brain tumor stem cells overcomes drug-resistance in preclinical models (Conference Presentation)
Bryan Q. Spring
Author Affiliations +
Proceedings Volume 11070, 17th International Photodynamic Association World Congress; 110701E (2019) https://doi.org/10.1117/12.2527769
Event: 17th International Photodynamic Association World Congress, 2019, Cambridge, Massachusetts, United States
Abstract
Standard chemoradiation often enriches drug-resistant tumor cell populations that can lead to recurrent and treatment-refractory disease. For instance, preclinical models of several cancers suggest that the cancer stem cell subpopulation becomes enriched and re-populates the tumor milieu following conventional therapies. Here, we show evidence that photodynamic therapy (PDT) is effective against several patient-derived glioblastoma stem cell cultures. Moreover, sub-lethal PDT results in re-sensitization of cancer cell phenotypes with induced drug-resistance to chemotherapy. This talk will also introduce some of our efforts to establish a new program aimed at developing personalized and targeted PDT to overcome drug-resistance.
Conference Presentation
© (2019) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Bryan Q. Spring "Photodynamic therapy of brain tumor stem cells overcomes drug-resistance in preclinical models (Conference Presentation)", Proc. SPIE 11070, 17th International Photodynamic Association World Congress, 110701E (14 August 2019); https://doi.org/10.1117/12.2527769
Advertisement
Advertisement
KEYWORDS
Photodynamic therapy

Stem cells

Tumors

Brain

Cancer

Therapeutics

Tumor growth modeling

Back to Top